Hennion & Walsh Asset Management, Inc. Geron Corp Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Geron Corp stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 371,035 shares of GERN stock, worth $512,028. This represents 0.02% of its overall portfolio holdings.
Number of Shares
371,035
Previous 388,176
4.42%
Holding current value
$512,028
Previous $640,000
18.28%
% of portfolio
0.02%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding GERN
# of Institutions
282Shares Held
509MCall Options Held
884KPut Options Held
564K-
Ra Capital Management, L.P. Boston, MA60.4MShares$83.3 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$64.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$59.3 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA35.6MShares$49.1 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$37.6 Million8.13% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $521M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...